{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:06:06Z","timestamp":1793660766132,"version":"4.5.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.phrs.2023.106805","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T11:51:53Z","timestamp":1684929113000},"page":"106805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"193","author":[{"given":"Chiara","family":"Mameli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Orso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Calcaterra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata Gabriela","family":"Wasniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Aversa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Granato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Bruschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Guadagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"d\u2019Angela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Spandonaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Polistena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianvincenzo","family":"Zuccotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2023.106805_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000446958","article-title":"Height outcome of recombinant human growth hormone treatment in achondroplasia children: a meta-analysis","volume":"86","author":"Miccoli","year":"2016","journal-title":"Horm. Res. Paediatr."},{"issue":"6","key":"10.1016\/j.phrs.2023.106805_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.eprac.2022.02.013","article-title":"Association of daily growth hormone injection adherence and height among children with growth hormone deficiency","volume":"28","author":"Loftus","year":"2022","journal-title":"Endocr. Pract.: Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106805_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264403","article-title":"Pediatric growth hormone treatment in Italy: a systematic review of epidemiology, quality of life, treatment adherence, and economic impact","volume":"17","author":"Orso","year":"2022","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.phrs.2023.106805_bib4","doi-asserted-by":"crossref","first-page":"e2121","DOI":"10.1210\/clinem\/dgz149","article-title":"Long-acting growth hormone preparations - current status and future considerations","volume":"105","author":"Miller","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.phrs.2023.106805_bib5","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1080\/03007995.2021.1982682","article-title":"Suboptimal adherence to daily growth hormone in a US real-world study: an unmet need in the treatment of pediatric growth hormone deficiency","volume":"37","author":"Loftus","year":"2021","journal-title":"Curr. Med Res Opin."},{"key":"10.1016\/j.phrs.2023.106805_bib6","doi-asserted-by":"crossref","first-page":"1014743","DOI":"10.3389\/fendo.2022.1014743","article-title":"Persistence with daily growth hormone among children and adolescents with growth hormone deficiency in the UK","volume":"13","author":"Loftus","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"n71","key":"10.1016\/j.phrs.2023.106805_bib7","first-page":"372","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2023.106805_bib8","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2023.106805_bib9","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2023.106805_bib10","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2023.106805_bib11","unstructured":"Institute of Health Economics (IHE). Quality Appraisal of Case Series Studies Checklist. Edmonton (AB): Institute of Health Economics; 2014. Available from: \u3008http:\/\/www.ihe.ca\/research-programs\/rmd\/cssqac\/cssqac-about\u3009."},{"issue":"2","key":"10.1016\/j.phrs.2023.106805_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0266462305050324","article-title":"Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria","volume":"21","author":"Evers","year":"2005","journal-title":"Int J. Technol. Assess. Health Care"},{"key":"10.1016\/j.phrs.2023.106805_bib13","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.0","article-title":"Chapter 10: analysing data and undertaking meta-analyses","author":"Deeks","year":"2019"},{"key":"10.1016\/j.phrs.2023.106805_bib14","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.0","article-title":"Chapter 13: assessing risk of bias due to missing results in a synthesis","author":"Page","year":"2019"},{"key":"10.1016\/j.phrs.2023.106805_bib15","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.0","article-title":"Chapter 14: completing \u2018summary of findings\u2019 tables and grading the certainty of the evidence","author":"Sch\u00fcnemann","year":"2019"},{"key":"10.1016\/j.phrs.2023.106805_bib16","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), accessed 12 October 2020. Available at gradepro.org."},{"issue":"5","key":"10.1016\/j.phrs.2023.106805_bib17","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1210\/jc.2016-3776","article-title":"A randomized phase 2 study of long-acting transCon GH vs daily GH in childhood GH deficiency","volume":"102","author":"Chatelain","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2023.106805_bib18","first-page":"120","article-title":"Long-term safety and effectiveness of daily and weekly growth hormone treatment in pediatric GHD patients (4-years' results)","volume":"86","author":"Chung","year":"2016","journal-title":"Horm. Res. Paediatr."},{"issue":"7","key":"10.1016\/j.phrs.2023.106805_bib19","doi-asserted-by":"crossref","first-page":"E2717","DOI":"10.1210\/clinem\/dgac220","article-title":"Efficacy and safety of weekly somatrogon vs daily somatropin in children with growth hormone deficiency: a phase 3 study","volume":"107","author":"Deal","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.phrs.2023.106805_bib20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1515\/jpem-2021-0735","article-title":"Evaluation of efficacy and safety of long-acting PEGylated recombinant human growth hormone (Jintrolong) for patients with growth hormone deficiency","volume":"35","author":"Du","year":"2022","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2023.106805_bib21","doi-asserted-by":"crossref","DOI":"10.1159\/000524600","article-title":"Efficacy and safety of once-weekly somatrogon compared with once-daily somatropin (Genotropin\u00ae) in Japanese children with pediatric growth hormone deficiency: results from a randomized phase 3 study","author":"Horikawa","year":"2022","journal-title":"Horm. Res. Paediatr."},{"issue":"2","key":"10.1016\/j.phrs.2023.106805_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/EJE-13-0148","article-title":"Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency","volume":"169","author":"Hwang","year":"2013","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106805_bib23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1210\/jc.2013-2502","article-title":"24-month use of once-weekly GH, LB03002, in prepubertal children with GH deficiency","volume":"99","author":"Khadilkar","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2023.106805_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EJE-16-0905","article-title":"Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies","volume":"177","author":"Luo","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.phrs.2023.106805_bib25","first-page":"88","article-title":"12-month effects of once-weekly and twice-monthly administration of hybrid Fc-fused human growth hormone, GX-H9, treatment in pediatric with GHD deficiency","volume":"90","author":"Malieyskiy","year":"2018","journal-title":"Horm. Res. Paediatr."},{"issue":"2","key":"10.1016\/j.phrs.2023.106805_bib26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2011-2234","article-title":"Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD)","volume":"97","author":"Peter","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2023.106805_bib27","doi-asserted-by":"crossref","first-page":"1438723","DOI":"10.1155\/2019\/1438723","article-title":"Use of PEGylated recombinant human growth hormone in Chinese children with growth hormone deficiency: a 24-month follow-up study","volume":"2019","author":"Qiao","year":"2019","journal-title":"Int. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106805_bib28","doi-asserted-by":"crossref","first-page":"e1847","DOI":"10.1210\/clinem\/dgz310","article-title":"Once-Weekly Somapacitan Vs Daily Gh In Children With GH deficiency: results from a randomized phase 2 trial","volume":"105","author":"S\u00e4vendahl","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.phrs.2023.106805_bib29","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/clinem\/dgab928","article-title":"Replacement with once-weekly somapacitan vs daily GH in children with GHD: 3-year results from REAL 3","volume":"107","author":"S\u00e4vendahl","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2023.106805_bib30","article-title":"Reduced effectiveness and comparable safety in biweekly vs. weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency: a phase IV non-inferiority threshold targeted trial","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"11","key":"10.1016\/j.phrs.2023.106805_bib31","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1210\/clinem\/dgab529","article-title":"Weekly lonapegsomatropin in treatment-na\u00efve children with growth hormone deficiency: the phase 3 heiGHt trial","volume":"106","author":"Thornton","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.phrs.2023.106805_bib32","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1210\/jc.2016-3547","article-title":"Long-acting C-terminal peptide-modified hGH (MOD-4023): results of a safety and dose-finding study in GHD children","volume":"102","author":"Zelinska","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2023.106805_bib33","first-page":"107","article-title":"Treatment adherence to somavaratan (VRS-317), a long-acting growth hormone for children with growth hormone deficiency (GHD): the VISTA trial","volume":"34","author":"Humphriss","year":"2017","journal-title":"J. Pediatr. Nurs. -Nurs. Care Child. Fam."},{"issue":"7","key":"10.1016\/j.phrs.2023.106805_bib34","doi-asserted-by":"crossref","first-page":"e2680","DOI":"10.1210\/clinem\/dgac217","article-title":"Safety and efficacy of lonapegsomatropin in children with growth hormone deficiency: enliGHten Trial 2-year results","volume":"107","author":"Maniatis","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2023.106805_bib35","doi-asserted-by":"crossref","DOI":"10.1159\/000524003","article-title":"Switching to weekly lonapegsomatropin from daily somatropin in children with growth hormone deficiency: the fliGHt trial","author":"Maniatis","year":"2022","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.phrs.2023.106805_bib36","first-page":"71","article-title":"First report of disease-specific patient-reported outcomes from a randomized phase 2 trial of once-weekly somapacitan versus daily GH in children with GHD","volume":"93","author":"Brod","year":"2020","journal-title":"Horm. Res. Paediatr."},{"issue":"S506-S","key":"10.1016\/j.phrs.2023.106805_bib37","article-title":"Evaluation of quality of life in pre-pubertal children using the quality of life in short stature youth (qolissy) questionnaire, following 12 months of growth hormone treatment with either a weekly somatrogon or a daily genotropin injection schedule","volume":"23","author":"Loftus","year":"2020","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.phrs.2023.106805_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17425247.2022.2027365","article-title":"TransCon human growth hormone for children with growth hormone deficiency: a technology evaluation","volume":"19","author":"Dos Santos","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"issue":"S218-S","key":"10.1016\/j.phrs.2023.106805_bib39","first-page":"1","article-title":"Dyadic evaluation of patient and caregiver treatment burden with once weekly growth hormone (GH) INJECTION SCHEDULE (SOMATROGON) VS. Once daily gh injection schedule (somatropin) by baseline burden subgroup in paediatric growth hormone deficiency (GHD)","volume":"25","author":"Loftus","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.phrs.2023.106805_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.726172","article-title":"Effect of weekly long-acting growth hormone replacement therapy compared to daily growth hormone on children with short stature: a meta-analysis","volume":"12","author":"Ma","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106805_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12020-019-01950-9","article-title":"Efficacy and safety of long-acting growth hormone in children with short stature: a systematic review and meta-analysis","volume":"65","author":"Yang","year":"2019","journal-title":"Endocrine"},{"issue":"Supplement_1","key":"10.1016\/j.phrs.2023.106805_bib42","doi-asserted-by":"crossref","first-page":"A680","DOI":"10.1210\/jendso\/bvab048.1388","article-title":"Perception of treatment burden with once weekly somatrogon vs once daily genotropin in pediatric patients with growth hormone deficiency (GHD): results from a randomized phase 3 study","volume":"5","author":"Maniatis","year":"2021","journal-title":"J. Endocr. Soc."},{"issue":"1","key":"10.1016\/j.phrs.2023.106805_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016223","article-title":"Non-compliance with growth hormone treatment in children is common and impairs linear growth","volume":"6","author":"Cutfield","year":"2011","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.phrs.2023.106805_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000350251","article-title":"Understanding the growth hormone therapy adherence paradigm: a systematic review","volume":"79","author":"Fisher","year":"2013","journal-title":"Horm. Res. Paediatr."},{"issue":"4","key":"10.1016\/j.phrs.2023.106805_bib45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000493211","article-title":"Identifying potentially modifiable factors associated with treatment non-adherence in paediatric growth hormone deficiency: a systematic review","volume":"90","author":"Graham","year":"2018","journal-title":"Horm. Res. Paediatr."},{"issue":"5","key":"10.1016\/j.phrs.2023.106805_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250993","article-title":"Regimen simplification and medication adherence: fixed-dose versus loose-dose combination therapy for type 2 diabetes","volume":"16","author":"Bohm","year":"2021","journal-title":"PloS One"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823001615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823001615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:43:05Z","timestamp":1760913785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823001615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":46,"alternative-id":["S1043661823001615"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106805","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106805"}}